Biopharma | June 05, 2026
Suven Life reports positive interim review for phase 3 Alzheimer’s therapy
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized
CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
Based in the global marketing function, he will be responsible for strengthening the company's visibility among sponsors, partners and industry stakeholders worldwide
Proprietary technologies in LNP-based delivery of mRNA and DNA vectors to advance T-CURX innovative in vivo CAR-T assets into clinical trials one year earlier
The approval marks a major milestone in the global fight against antimicrobial resistance
The designation marks the first Breakthrough Therapy recognition for calderasib and is backed by positive results from the Phase 1 KANDLELIT-001 clinical trial
The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer
First-in-human study of investigational SOS1 inhibitor shows encouraging safety profile and early anti-tumor activity in patients with metastatic solid tumors
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
